Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia
Condition: Influenza Interventions: Drug: N-acetyl cysteine; Drug: 5% Dextrose Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2019 Category: Research Source Type: clinical trials
Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza
Condition: Influenza Interventions: Drug: sirolimus and oseltamivir; Drug: Oseltamivir Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2019 Category: Research Source Type: clinical trials
Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia
Condition: Influenza Interventions: Drug: N-acetyl cysteine; Drug: 5% Dextrose Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2019 Category: Research Source Type: clinical trials
Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza
Condition: Influenza Interventions: Drug: sirolimus and oseltamivir; Drug: Oseltamivir Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2019 Category: Research Source Type: clinical trials
Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia
Condition: Influenza Interventions: Drug: N-acetyl cysteine; Drug: 5% Dextrose Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2019 Category: Research Source Type: clinical trials
Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza
Condition: Influenza Interventions: Drug: sirolimus and oseltamivir; Drug: Oseltamivir Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2019 Category: Research Source Type: clinical trials
Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia
Condition: Influenza Interventions: Drug: N-acetyl cysteine; Drug: 5% Dextrose Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2019 Category: Research Source Type: clinical trials
Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza
Condition: Influenza Interventions: Drug: sirolimus and oseltamivir; Drug: Oseltamivir Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2019 Category: Research Source Type: clinical trials
Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia
Condition: Influenza Interventions: Drug: N-acetyl cysteine; Drug: 5% Dextrose Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2019 Category: Research Source Type: clinical trials
Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza
Condition: Influenza Interventions: Drug: sirolimus and oseltamivir; Drug: Oseltamivir Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2019 Category: Research Source Type: clinical trials
Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia
Condition: Influenza Interventions: Drug: N-acetyl cysteine; Drug: 5% Dextrose Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2019 Category: Research Source Type: clinical trials
Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza
Condition: Influenza Interventions: Drug: sirolimus and oseltamivir; Drug: Oseltamivir Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2019 Category: Research Source Type: clinical trials